Full-body Scams, er a ... ScansWritten by Stephen Bucaro
Permission is granted for following article to forward, reprint, distribute, use for ezine, newsletter, website, offer as free bonus or part of a product for sale as long as no changes are made and byline, copyright, and resource box is included. ---------------------------------------------------------- Full-body Scams, er a ... ScansBy Stephen Bucaro Full-body CT (Computer Tomography) scanners are appearing in strip malls and office centers all over country. Many doctors are recommending a full-body CT scan (follow kick-back money). The sales pitch; "A full-body scan can find disease early when it is more treatable." The scans cost between $600.00 and $3,000.00 and are not covered by Medicare or health insurance plans when no symptoms exist. The scam is most profitable when perpetrated against individuals over 50 years of age. Scans of individuals in this age group often show scars from long ago healed cysts and benign spots on kidney, liver, or pancreas. Doctors and hospitals can use these meaningless irregularities to generate thousands of dollars in unnecessary tests. False positive test results can generate profits from biopsies and invasive surgeries. CT scans provide most profitable but poorest quality of medical imaging. Contrast agents can be used to make CT scans more accurate, but fast-buck consumer imaging centers don't use contrast agents. Ultrasound and MRI (Magnetic Resonance Imaging) scans provide much sharper images, but a lower profit margin. The result is, CT scan might give you false security of perfect health when a killer disease exists.
| | Strattera, The New ADHD MedicationWritten by Jeannine Virtue
"Strattera, New ADHD Medication" The newest ADHD medication Strattera (atomoxetine) is expected to hit pharmacy shelves this month to much ado. What separates Strattera (atomoxetine) from rest of ADHD medications pack is that Strattera (atomoxetine) is first non-stimulant medication FDA-approved for Attention Deficit Disorder. Strattera (atomoxetine) is not a controlled substance under Controlled Substance Act, which translates to convenience of phone-in refills and less prescription hassles at pharmacy. Strattera (atomoxetine) is an oral capsule prescribed in a once or twice daily dose, which also eliminates need for school children to medicate during school day. And, Strattera (atomoxetine) is only ADHD medication FDA-approved for adults. But before you knock on your doctor's door asking for a prescription, there are a few things you should know about this new ADHD medication. Although Strattera (atomoxetine) is a non-stimulant ADHD medication, it still poses many side effects consistent with side effects of other ADHD medications - and a few new ones that adults might find less than pleasant. Common Strattera (atomoxetine) Side Effects include (but not limited to): _ Problems sleeping/Insomnia _ Dry mouth _ Decreased appetite _ Weight loss _ Upset stomach _ Constipation _ Nausea and/or vomiting _ Dizziness _ Tiredness _ Mood swings _ Ear infection _ Influenza _ Irritability Sexual side effects (in adults studied): _ Decreased libido _ Ejaculatory problems _ Impotence _ Urination problems _ Painful menstrual periods The following, though rare, have also been reported: _ Strattera (atomoxetine) can cause potentially serious allergic reactions. Strattera (atomoxetine) can increase heart rate and blood pressure. Strattera (atomoxetine) can also worsen conditions of high blood pressure and heart disease. Strattera (atomoxetine) should not be taken at same time as, or within two weeks of taking, a monoamine oxidase inhibitor. Patients with narrow angle glaucoma should not take Strattera (atomoxetine). You should alert prescribing physician of following condition before beginning Strattera (atomoxetine); _ Current or past depression, psychosis or other mental conditions _ Alcohol or drug abuse _ Heart disease _ High blood pressure _ Epilepsy or seizure disorders _ Liver disease or kidney disease _ Pregnancy, nursing or plans to become pregnant Strattera (atomoxetine) makers Eli Lilly and Company conducted six placebo-controlled studies in children, adolescents and adults for FDA submission. Early studies suggest that potential of abuse is lower with Strattera (atomoxetine) and side effects may not be as pronounced as with other ADHD medications.
|
